Spots Global Cancer Trial Database for Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
Official Title: Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
Study ID: NCT03612804
Study Description
Brief Summary: This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
Detailed Description: This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lung cancer screening process. Key proactive elements include proactive telephone outreach to all current smokers by a VA Quitline counselor that follows mailed results letters, and providing providers guidance in offering proactive cessation medication support as part of the lung cancer screening process.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, New York, United States
Providence VA Medical Center, Providence, RI, Providence, Rhode Island, United States
VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States
Contact Details
Name: Steven B. Zeliadt, PhD MPH
Affiliation: VA Puget Sound Health Care System Seattle Division, Seattle, WA
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
